García-Álvarez, María
Alonso-Álvarez, Sara
Prieto-Conde, Isabel
Jiménez, Cristina
Sarasquete, M. Eugenia
Chillón, M. Carmen
Medina, Alejandro
Balanzategui, Ana
Maldonado, Rebeca
Antón, Alicia
Puig, Noemí
Rodríguez, Marta
Blanco, Oscar
Tamayo, Pilar
González-Calle, Verónica
Martín, Alejandro
García-Sanz, Ramón http://orcid.org/0000-0003-4120-2787
González, Marcos
Caballero, M. Dolores
Alcoceba, Miguel http://orcid.org/0000-0002-3819-4846
Article History
Received: 26 November 2018
Revised: 23 January 2019
Accepted: 3 April 2019
First Online: 17 June 2019
Conflict of interest
: The authors reports grants PI15/01393, PI18-00410, CAS102P17, GRS 1180/A/15, GLD17/00334, CIBERONC-CB16/12/00233 during the conduct of the study, and from Gilead Sciences (GLD15/00348, GLD16/00162), Incyte, Janssen, and Amgen outside the submitted work. M.G.A., I.P.C., C.J., V.G.C. and M.E.S. are or were supported by the Spanish government (ISCIII and/or FEHH). Consulting fees and/or non-financial support were reported from Abbvie (M.G.), Amgen (N.P., M.D.C), BMS (R.G-S., M.D.C.), Celgene (N.P., A.M., M.D.C), Gilead (A.M., M.G., M.D.C.), Incyte (R.G-S.), Janssen (N.P., A.M., R.G-S., M.G., M.D.C., M.A.), Kite (M.D.C.), MSD (M.D.C.), Novartis (S.A-A., M.D.C.), Prothena (V.G-C.), Roche (A.M., M.G., M.D.C.), Servier (A.M.), Takeda (N.P., R.G-S., M.D.C.), and Weber (N.P.). R.G-S. is the president of the Spanish Society of Haematology. The remaining authors declare no competing interests.